52 Holden Maecker et al., “Vaccination with Allergin-IL-18 Fusion DNA Protects Against, and Reverses Established, Airway Hyperreactivity in a Murine Asthma Model”, Journal of Immunology 166 (2001), 959–965.

53 Braun-Fahrländer et al., “Environmental Exposure to Endotoxin”.

54 Waltraud Eder et al., “Toll-like Receptor 2 as a Major Gene for Asthma in Children of European Farmers”, Journal of Allergy and Clinical Immunology 113 (2004), 482–488.

55 John M. Grange, “Effective Vaccination Against Tuberculosis – A New Ray of Hope”, Clinical and Experimental Immunology 120 (2000), 232–234.

56 Christian Lienhardt, Alimuddin Zumla, “BCG: The Story Continues”, Lancet 366 (2005), 1414–1416.

57 G. M. Bahr et al., “Two Potential Improvements to BCG and Their Effect on Skin Test Reactivity in the Lebanon”, Tubercle 67 (1986), 205–216; John Stanford, “Improving on BCG”, Acta Pathologica, Microbiologica et Immunologica 99 (1991), 103–113.

58 G. D. Prema et al., “A Preliminary Report on the Immunotherapy of Psoriasis”, Indian Medical Gazette 124 (1990), 381–382.